Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Related Citations for PubMed (Select 18056992)


A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.

Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E.

J Biol Chem. 2008 Jan 25;283(4):2031-41. Epub 2007 Dec 5.


Extracellular HSP90: conquering the cell surface.

Sidera K, Patsavoudi E.

Cell Cycle. 2008 Jun 1;7(11):1564-8. Epub 2008 Apr 2.


Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.

Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J, Kumar R.

J Biol Chem. 1998 Oct 23;273(43):28238-46.


Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.

Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC, Lupu R.

Int J Oncol. 2000 Oct;17(4):629-41.


MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.

Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D.

Oncogene. 2006 Jan 5;25(1):20-31.


HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion.

Taiyab A, Rao ChM.

Biochim Biophys Acta. 2011 Jan;1813(1):213-21. doi: 10.1016/j.bbamcr.2010.09.012. Epub 2010 Sep 29.


Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line.

Kushima Y, Iida K, Nagaoka Y, Kawaratani Y, Shirahama T, Sakaguchi M, Baba K, Hara Y, Uesato S.

Biol Pharm Bull. 2009 May;32(5):899-904.


Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.

Liu X, Yan Z, Huang L, Guo M, Zhang Z, Guo C.

Oncol Rep. 2011 May;25(5):1343-51. doi: 10.3892/or.2011.1202. Epub 2011 Mar 1.


Identification of new biomarkers for clinical trials of Hsp90 inhibitors.

Zhang H, Chung D, Yang YC, Neely L, Tsurumoto S, Fan J, Zhang L, Biamonte M, Brekken J, Lundgren K, Burrows F.

Mol Cancer Ther. 2006 May;5(5):1256-64.


Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion.

El Hamidieh A, Grammatikakis N, Patsavoudi E.

PLoS One. 2012;7(8):e42722. doi: 10.1371/journal.pone.0042722. Epub 2012 Aug 17.


Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling.

Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song CZ, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D'Amour KA, Chesnut JD, Rao MS, Blau CA, Robins AJ.

Blood. 2007 Dec 1;110(12):4111-9. Epub 2007 Aug 29.


Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.

Fu XD, Giretti MS, Baldacci C, Garibaldi S, Flamini M, Sanchez AM, Gadducci A, Genazzani AR, Simoncini T.

PLoS One. 2008 Jul 30;3(7):e2790. doi: 10.1371/journal.pone.0002790.


Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.

Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.

Mol Cancer Res. 2009 Feb;7(2):275-84. doi: 10.1158/1541-7786.MCR-07-2183. Epub 2009 Feb 10.


Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, Pisacane PI, Lofgren JA, Tindell C, Evans DP, Maiese K, Scher HI, Sliwkowski MX.

Cancer Cell. 2002 Aug;2(2):127-37.


Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry.

Esteva FJ, Hortobagyi GN, Sahin AA, Smith TL, Chin DM, Liang SY, Pusztai L, Buzdar AU, Bacus SS.

Pathol Oncol Res. 2001;7(3):171-7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk